Stock 300401 ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Zhejiang Garden Biopharmaceutical Co.,Ltd.

Equities

300401

CNE100001XX7

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 15/07/2024 BST 		5-day change 1st Jan Change
14.51 CNY +5.14% Intraday chart for Zhejiang Garden Biopharmaceutical Co.,Ltd. -1.96% +22.86%
04-15 Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-20 Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zhejiang Garden Biopharmaceutical Co.,Ltd. Approves Final Cash Dividend on A Shares for the Year 2023, Payable on 15 May 2024
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has completed with 9,307,200 shares, representing 1.7% for CNY 100 million.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments
CI
Zhejiang Garden Biopharmaceutical's Unit Gets Nod for Eight New Products
MT
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 7, 2023.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. authorizes a Buyback Plan.
CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Zhejiang Garden Biopharma Registers Acid Reflux Drug
MT
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 24, 2023
CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. has Changed its Name to Zhejiang Garden Biopharmaceutical Co., Ltd
CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300401 Stock
  4. News Zhejiang Garden Biopharmaceutical Co.,Ltd.